Trends in 28-day and 1-year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001-2009: A Cardiovascular disease in Norway (CVDNOR) project

Journal of Internal Medicine

Volumn 277, Issue 3, 2015, Pages 353-361

  Sulo, E ^a   Vollset, S E ^a,b   Nygard O ^a,c   Sulo, G ^a   Igland, J ^a   Egeland, G M ^a,b   Ebbing, M ^b   Tell, G S ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myocardial infarction; Mortality rates; Norway; Trends

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; FEMALE; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; VERY ELDERLY; AGE DISTRIBUTION; CLINICAL TRIAL; EPIDEMIOLOGY; HEART INFARCTION; HOSPITALIZATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; SEX RATIO; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PROGNOSIS; SEX DISTRIBUTION;

EID: 84923092921     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12266     Document Type: Article

References (34)

1. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009; 16: 333-50.
2. Reikvam A, Hagen TP. Changes in myocardial infarction mortality. Tidsskr Nor Laegeforen 2011; 131: 468-70.
3. O'Flaherty M, Buchan I, Capewell S. Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart 2013; 99: 159-62.
4. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57.
5. Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet 2000; 355: 688-700.
6. Roger VL. Myocardial infarction outcomes: 'the times, they are a-changin...'. Circ Cardiovasc Qual Outcomes 2010; 3: 568-70.
7. Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012; 344: e356.
8. Koopman C, Bots ML, van Oeffelen AA et al. Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol 2013; 168: 993-8.
9. Dudas K, Lappas G, Rosengren A. Long-term prognosis after hospital admission for acute myocardial infarction from 1987 to 2006. Int J Cardiol 2012; 155: 400-5.
10. Kostis WJ, Deng Y, Pantazopoulos JS, Moreyra AE, Kostis JB. Trends in mortality of acute myocardial infarction after discharge from the hospital. Circ Cardiovasc Qual Outcomes 2010; 3: 581-9.
11. Roger VL, Weston SA, Gerber Y et al. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation 2010; 121: 863-9.
12. Oyen N, Nygard O, Igland J, et al. Hospital admission rates for cardiovascular diseases in Western Norway, 1992-2001. Tidsskr Nor Laegeforen 2008; 128: 17-23.
13. Mannsverk J, Wilsgaard T, Njolstad I et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The tromso study. Eur J Prev Cardiol 2012; 19: 927-34.
14. Langorgen J, Igland J, Vollset SE et al. Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infarction, 1979-2001: the Western Norway cardiovascular registry. Eur J Cardiovasc Prev Rehabil 2009; 16: 621-7.
15. Sulo G, Igland J, Vollset SE, Nygård O, Øyen N, Tell GS. Cardiovascular disease and diabetes mellitus in Norway during 1994-2009:CVDNOR - a nationwide research project. Norsk Epidemiologi 2013; 23: 101-7.
16. Igland J, Tell GS, Ebbing M, Nygård O, Vollset SE, T D. The CVDNOR project: Cardiovascular Disease in Norway 1994-2009. Description of data and data quality 2013. [cited 2013 29 November]. Available from: http://cvdnor.b.uib.no/about-cvdnor/publications/.
17. Sulo G, Igland J, Nygard O, Vollset SE, Ebbing M, Tell GS. Favourable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project. Eur J Prev Cardiol 2013; PMID: 23847184 [Epub ahead of print].
18. Sala C, Grau M, Masia R et al. Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments. Am Heart J 2011; 162: 444-50.
19. Davies CA, Leyland AH. Trends and inequalities in short-term acute myocardial infarction case fatality in Scotland, 1988-2004. Popul Health Metr 2010; 8: 33.
20. Fox KA, Steg PG, Eagle KA et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 1892-900.
21. Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC Jr. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2009; 119: 503-14.
22. Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.
23. Hamm CW, Bassand JP, Agewall S et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
24. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol 2008; 51: 1247-54.
25. Salomaa V, Paakkonen R, Hamalainen H, Niemi M, Klaukka T. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2007; 14: 386-91.
26. Rogers AM, Ramanath VS, Grzybowski M et al. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J 2007; 154: 461-9.
27. Ho PM, Spertus JA, Masoudi FA et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-7.
28. Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol 2007; 22: 145-9.
29. Blix HS, Landmark K, Selmer R, Reikvam A. Patterns in the prescription of antihypertensive drugs in Norway, 1975-2010. Tidsskr Nor Laegeforen 2012; 132: 1224-1228.
30. Walley T, Folino-Gallo P, Schwabe U, van Ganse E, EuroMedStat g. Variations and increase in use of statins across Europe: data from administrative databases. BMJ 2004; 328: 385-6.
31. Melander A, Folino-Gallo P, Walley T et al. Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia 2006; 49: 2024-9.
32. Reikvam A, Kvan E, Aursnes I. Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy. Cardiovasc Drugs Ther 2002; 16: 451-6.
33. Langorgen J, Ebbing M, Igland J et al. Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited. Eur J Prev Cardiol 2013; PMID: 23733742 [Epub ahead of print].
34. Osler M, Rostgaard K, Sorensen TI, Madsen M. The effect of recurrent events on register-based estimates of level and trends in incidence of acute myocardial infarction. J Clin Epidemiol 1999; 52: 595-600.